Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia

Blood

Volumn 99, Issue 3, 2002, Pages 1092-1094

  Ghazal, Hassan ^a  

^a Kentucky Cancer Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE; RITUXIMAB;

ADULT; AGED; ARTICLE; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PURE RED CELL ANEMIA; TREATMENT OUTCOME;

EID: 0036464612     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.3.1092     Document Type: Article

References (15)

1. Pure red cell aplasia in patients with chronic lymphocytic leukemia
2. Acquired pure red cell aplasia associated with chronic lymphocytic leukemia
3. The anti-tumor effect of monoclonal anti-CD20 antibody (mAb) therapy includes direct anti-proliferative activity and induction of apoptosis in CD20 positive non-Hodgkin's lymphoma (NHL) cell lines
4. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
5. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of the patients responded to a four-dose treatment program
6. Anti-CD 20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia
7. Chronic cold agglutinin disease of the "idiopathic" type is a premalignant or low-grade malignant lymphoproliferative disease
8. Treatment with anti-CD20 antibodies of patients with autoimmune thrombocytopenia with or without hemolytic anemia: Worsening in hemoglobin level
9. Rituxan in the treatment of autoimmune hemolytic anemia (AHIA)
10. Rituximab, cyclophosphamide and decadron combination is highly effective in autoimmune hemolytic anemia associated with chronic lymphocytic leukemia
11. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: A report of three cases
12. Evidence for reduced erythroid burst (BFU-E) promoting function of T lymphocytes in the pure red cell aplasia of chronic lymphocytic leukemia
13. T gamma (Tγ) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia
14. Hypoplastic anemia in B cell chronic lymphocytic leukemia: Evolution of T cell mediated suppression of erythropoiesis in early-stage and late-stage disease
15. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab